Related Experiment Video
Updated: Nov 30, 2025

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Persistent Cancer Cells: The Deadly Survivors
Shensi Shen1, Stéphan Vagner2, Caroline Robert3
1INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France.
Abstract:
Persistent cancer cells are the discrete and usually undetected cells that survive cancer drug treatment and constitute a major cause of treatment failure. These cells are characterized by their slow proliferation, highly flexible energy consumption, adaptation to their microenvironment, and phenotypic plasticity. Mechanisms that underlie their persistence offer highly coveted and sought-after therapeutic targets, and include diverse epigenetic, transcriptional, and translational regulatory processes, as well as complex cell-cell interactions. Although the successful clinical targeting of persistent cancer cells remains to be realized, immense progress has been made in understanding their persistence, yielding promising preclinical results.
Insights
Persistent cancer cells survive treatment, causing failure. Understanding their complex survival mechanisms offers new therapeutic targets for cancer treatment, with promising preclinical results.
Area of Science:
- Oncology
- Cancer Biology
- Cellular Mechanisms
Background:
- Persistent cancer cells evade therapy, leading to treatment failure.
- These cells exhibit slow proliferation, metabolic flexibility, and phenotypic plasticity.
- Their survival involves epigenetic, transcriptional, and translational regulation, plus cell interactions.
Purpose of the Study:
- To explore the mechanisms underlying persistent cancer cell survival.
- To identify potential therapeutic targets for eliminating these cells.
Main Methods:
- Review of current literature on persistent cancer cell biology.
- Analysis of epigenetic, transcriptional, and translational regulatory processes.
- Investigation of cell-cell interactions in cancer persistence.
Main Results:
- Persistent cancer cells possess unique adaptive survival strategies.
- Diverse molecular and cellular mechanisms contribute to their persistence.
- Preclinical studies show promise in targeting these survival pathways.
Conclusions:
- Targeting persistent cancer cells is crucial for improving cancer treatment outcomes.
- Further research into their complex biology is needed for clinical translation.
- Developing therapies against these cells holds significant therapeutic potential.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Treatment Resistant Cancers
Cancer
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancers Originate from Somatic Mutations in a Single Cell

